Al Marbad Investments Life Sciences targets four types of investment opportunities.
Our team draws on deep industry expertise, clinical insights and cross-asset class investing experience to drive advances in therapeutics, diagnostics and tools to improve the lives of patients with unmet medical needs.
Al Marbad Investments Life Sciences invests in
biopharmaceutical, specialty pharmaceutical, medical device,
diagnostics and enabling life science technology companies
globally, with a focus on companies that both drive medical
innovation across the value chain and enable that innovation to
improve the lives of patients with unmet medical needs.
The differentiated skillset of Al Marbad Investments' team enables it to pursue opportunities created by several longterm trends in healthcare. In particular, these trends are creating an increased need for targeted capital and value-added strategic support of companies around their critical phases of growth, during which they must prove their clinical and business value.
Since 2015, Al Marbad Investments has employed a strategic, analytical approach to identify attractive investment opportunities and partner with management teams to transform and improve their businesses. During this time, Al Marbad Investments has developed global reach, deep expertise and a proven track record in the life sciences industries across its Private Equity, Public Equity, Credit, and Ventures business units
Scaling innovation in Life Science
Al Marbad Investments Life Sciences provides targeted and value-added support to pursue innovation that improves the lives of patients.
Targeting companies that drive innovation across
the healthcare value chain
Fundamental analysis and bottom-up stock picking.
Bringing breakthrough advances to market that
improve the lives of patients
Multi-year investment horizon.
Enabling efficient use of capital through rigorous diligence, asset selection and value-added support.